These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27574110)

  • 1. Parkinson's disease-related gene variants influence pre-mRNA splicing processes.
    Gaweda-Walerych K; Mohagheghi F; Zekanowski C; Buratti E
    Neurobiol Aging; 2016 Nov; 47():127-138. PubMed ID: 27574110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.
    Chung SJ; Kim MJ; Ryu HS; Kim J; Kim YJ; Kim K; You S; Kim SY; Lee JH
    Neurobiol Aging; 2017 Jan; 49():215.e9-215.e10. PubMed ID: 28340952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.
    Gaweda-Walerych K; Safranow K; Jasinska-Myga B; Bialecka M; Klodowska-Duda G; Rudzinska M; Czyzewski K; Cobb SA; Slawek J; Styczynska M; Opala G; Drozdzik M; Nishioka K; Farrer MJ; Ross OA; Wszolek ZK; Barcikowska M; Zekanowski C
    Parkinsonism Relat Disord; 2012 Jun; 18(5):520-4. PubMed ID: 22361577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease.
    Elliott DA; Kim WS; Gorissen S; Halliday GM; Kwok JB
    Mov Disord; 2012 Jul; 27(8):1004-11. PubMed ID: 22528366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside Re activation of nitric oxide signaling.
    Kim KH; Song K; Yoon SH; Shehzad O; Kim YS; Son JH
    J Biol Chem; 2012 Dec; 287(53):44109-20. PubMed ID: 23144451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
    Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
    Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease.
    De Mena L; Coto E; Sánchez-Ferrero E; Ribacoba R; Guisasola LM; Salvador C; Blázquez M; Alvarez V
    J Neural Transm (Vienna); 2009 Oct; 116(10):1289-93. PubMed ID: 19657588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
    Alvarez V; Corao AI; Sánchez-Ferrero E; De Mena L; Alonso-Montes C; Huerta C; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; García-Castro M; Coto E
    Neurosci Lett; 2008 Feb; 432(1):79-82. PubMed ID: 18248889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing: is there an alternative contribution to Parkinson's disease?
    La Cognata V; D'Agata V; Cavalcanti F; Cavallaro S
    Neurogenetics; 2015 Oct; 16(4):245-63. PubMed ID: 25980689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of rare variants in E3 ubiquitin ligase genes in Early onset Parkinson's disease.
    Gu X; Hou Y; Chen Y; Ou R; Cao B; Wei Q; Zhang L; Song W; Zhao B; Wu Y; Li C; Shang H
    Neurobiol Aging; 2022 Jan; 109():273-278. PubMed ID: 34544586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) does not activate transcription in mammalian mitochondria.
    Harmel J; Ruzzenente B; Terzioglu M; Spåhr H; Falkenberg M; Larsson NG
    J Biol Chem; 2013 May; 288(22):15510-9. PubMed ID: 23599432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine Parkin: molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant.
    Bjerre D; Madsen LB; Bendixen C; Larsen K
    Biochem Biophys Res Commun; 2006 Sep; 347(3):803-13. PubMed ID: 16844087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.
    Sánchez-Ferrero E; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Alvarez V
    Parkinsonism Relat Disord; 2009 Jul; 15(6):468-70. PubMed ID: 18980857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.